Americord Registry Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 11
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 1

Americord Registry General Information


Owner and operator of a biotech business that collects, processes and stores stem cells. The company is developing a proprietary process to harvest stem cells for future medical or therapeutic use.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare
Primary Office
  • 139 Fulton Street
  • Suite 901
  • New York, NY 10038
  • United States
+1 (866) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Americord Registry Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - PPP 15-Apr-2020 00000 Completed
1. Accelerator/Incubator 10-Jun-2014 00000 00000 Completed Profitable
To view Americord Registry’s complete valuation and funding history, request access »

Americord Registry Executive Team (4)

Name Title Board Seat Contact Info
Martin Smithmyer Founder, President & Chief Executive Officer
Robert Dracker Executive
Christina Roccos Vice President, Medical Partnerships and Programs
To view Americord Registry’s complete executive team members history, request access »

Americord Registry Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Americord Registry Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Start-up NY Accelerator/Incubator Minority 000 0000 000000 0
To view Americord Registry’s complete investors history, request access »